• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form SC 13G/A filed

    2/16/21 5:17:54 PM ET
    $TRIL
    Major Pharmaceuticals
    Health Care
    Get the next $TRIL alert in real time by email
    SC 13G/A 1 d130560dsc13ga.htm SC 13G/A SC 13G/A

     

     

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    WASHINGTON, D.C. 20549

     

     

    SCHEDULE 13G

    Under the Securities Exchange Act of 1934

    (Amendment No.    1)*

     

     

    Trillium Therapeutics Inc.

    (Name of Issuer)

    Common Shares, no par value

    (Title of Class of Securities)

    89620X506

    (CUSIP Number)

    December 31, 2020

    (Date of Event which Requires Filing of this Statement)

     

     

    Check the appropriate box to designate the rule pursuant to which this Schedule is filed:

    ☐ Rule 13d-1(b)

    ☒ Rule 13d-1(c)

    ☐ Rule 13d-1(d)

     

    *

    The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.

    The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).

     

     

     


    Page 2 of 7

    CUSIP No. 89620X506

     

      1    

      Name of reporting persons.

     

      Boxer Capital, LLC

      2  

      Check the appropriate box if a member of a group. (See instructions).

      (a)  ☐        (b)  ☒

     

      3  

      SEC use only.

     

      4  

      Citizenship or place of organization.

     

      Delaware

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      Sole voting power.

     

      -0-

       6   

      Shared voting power.

     

      -0-

       7   

      Sole dispositive power.

     

      -0-

       8   

      Shared dispositive power.

     

      -0-

      9    

      Aggregate amount beneficially owned by each reporting person.

     

      -0-

    10  

      Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

     

      ☐

    11  

      Percent of class represented by amount in row (9).

     

      0%*

    12  

      Type of reporting person

     

      OO


    Page 3 of 7

    CUSIP No. 89620X506

     

      1    

      Name of reporting persons.

     

      Boxer Asset Management Inc.

      2  

      Check the appropriate box if a member of a group. (See instructions).

      (a)  ☐        (b)  ☒

     

      3  

      SEC use only.

     

      4  

      Citizenship or place of organization.

     

      Bahamas

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      Sole voting power.

     

      -0-

       6   

      Shared voting power.

     

      -0-

       7   

      Sole dispositive power.

     

      -0-

       8   

      Shared dispositive power.

     

      -0-

      9    

      Aggregate amount beneficially owned by each reporting person.

     

      -0-

    10  

      Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

     

      ☐

    11  

      Percent of class represented by amount in row (9).

     

      0%

    12  

      Type of reporting person

     

      CO


    Page 4 of 7

    CUSIP No. 89620X506

     

      1    

      Name of reporting persons.

     

      Joe Lewis

      2  

      Check the appropriate box if a member of a group. (See instructions).

      (a)  ☐        (b)  ☒

     

      3  

      SEC use only.

     

      4  

      Citizenship or place of organization.

     

      United Kingdom

    NUMBER OF

    SHARES

     BENEFICIALLY 

    OWNED BY

    EACH

    REPORTING

    PERSON

    WITH:

       5     

      Sole voting power.

     

      -0-

       6   

      Shared voting power.

     

      -0-

       7   

      Sole dispositive power.

     

      -0-

       8   

      Shared dispositive power.

     

      -0-

      9    

      Aggregate amount beneficially owned by each reporting person.

     

      -0-

    10  

      Check box if the aggregate amount in row (9) excludes certain shares (see instructions).

     

      ☐

    11  

      Percent of class represented by amount in row (9).

     

      0%

    12  

      Type of reporting person

     

      IN


    Page 5 of 7

     

    This Amendment No. 1 (“Amendment No. 1”) amends and supplements the statement on Schedule 13G filed on February 3, 2020 (the “Original Filing”) by Boxer Capital, LLC (“Boxer Capital”), Boxer Asset Management Inc. (“Boxer Management”) and Joe Lewis (collectively, the “Reporting Persons”). The Original Filing remains in effect except to the extent that it is amended, restated or superseded by information contained in this Amendment No. 1. Capitalized terms used and not defined in this Amendment No. 1 have the meanings set forth in the Original Filing.

     

    Item 4.

    Ownership.

     

      (a)

    Amount beneficially owned:

    The Reporting Persons do not own any shares of Common Stock.

     

      (b)

    Percent of class:

    The Reporting Persons do not own any shares of Common Stock.                

     

      (c)

    Number of shares as to which such person has:

     

      (i)

    Sole power to vote or to direct the vote:

    None of the Reporting Persons has sole power to vote or to direct the vote of any shares of Common Stock.

     

      (ii)

    Shared power to vote or to direct the vote:

    None of the Reporting Persons has shared power to vote or to direct the vote of any shares of Common Stock.

     

      (iii)

    Sole power to dispose or to direct the disposition of:

    None of the Reporting Persons has sole power to dispose or to direct the disposition of any shares of Common Stock.

     

      (iv)

    Shared power to dispose or to direct the disposition of:

    None of the Reporting Persons has shared power to dispose or to direct the disposition of any shares of Common Stock.

     

    Item 5.

    Ownership of Five Percent or Less of a Class.

    With respect to each Reporting Person:

    If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the beneficial owner of more than 5 percent of the class of securities, check the following ☒.

     

    Item 10.

    Certification.

    (c) By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.


    Page 6 of 7

     

    Exhibits

     

      1

    Joint Filing Agreement, dated February 3, 2020, among the Reporting Persons, incorporated by reference to Exhibit 1 to the Original Filing.


    SIGNATURE

    After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

    February 16, 2021

     

      BOXER CAPITAL, LLC
      By:  

    /s/ Aaron I. Davis

      Name:   Aaron I. Davis
      Title:   Authorized Signatory
      BOXER ASSET MANAGEMENT INC.
      By:  

    /s/ Jason Callender

      Name:   Jason Callender
      Title:   Director
      JOSEPH C. LEWIS
     

    /s/ Joseph C. Lewis

      Joseph C. Lewis, Individually
    Get the next $TRIL alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $TRIL

    DatePrice TargetRatingAnalyst
    11/17/2021Buy → Hold
    The Benchmark Company
    11/17/2021Buy → Hold
    Benchmark
    8/24/2021$21.00 → $18.50Buy → Hold
    Craig-Hallum
    8/24/2021Market Outperform → Market Perform
    JMP Securities
    8/23/2021$22.00 → $18.50Buy → Neutral
    HC Wainwright & Co.
    More analyst ratings